COVID-19 Booster Vaccination in Persons With Multiple Sclerosis
Condition: PWMS Who Have Completed Vaccination Against COVID-19 and Test Negative for COVID-19 Spike Protein Antibodies Using a Commercial Assay Interventions: Biological: Homologous booster; Biological: Heterologous booster Sponsors: Griffin Hospital; Yale-Griffin Prevention Research Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials